[StephN]

Your HER2 group had a presence at this massive (over 15,000 attendees) annual meeting. We had a booth in the section of the exhibit area for non-profit organizations. We had good traffic flow with a corner location in a main traffic flow aisle. Hence it seems there was never more than a few moments when we were without someone stopping to see what we were all about.

Many of the researchers were easily engaged in conversation about their research and what they were presenting at this meeting. Sometimes there was a bit of a language barrier as the conference is international, and there are many foreigners working at univerisities and institutes in this country.

This conference covers ALL types of cancers, but often the work at the molecular level could cross over from one cancer to another. Also most of the presentations are using mouse models or cell lines and not to the point of human subjects.

There are a number of abstracts I would like to post, but online access to them will not be available for another week or so. Most have not yet been published elsewhere, so we have to wait for the AACR website to have them.

For me, the biggest surprise was how much new research is taking place in prevention and and the possible use of non-chemo agents in treatment. The discovery of ways to break down our DNA and the gene sequencing is proliferating a huge amount of work to find out where the mutations are and how they occur.

Stay tuned - more to come.

(Off to get my head examined - I mean have a routine brain MRI.)